| DB ID | MyCo_5781 |
| Title | MiR-150 levels are related to in-hospital mortality in non-HIV Pneumocystis pneumonia patients |
| Year | 2024 |
| PMID | 38471665 |
| Fungal Diseases involved | Pneumocystis pneumonia |
| Associated Medical Condition | None |
| Genus | Pneumocystis |
| Species | spp. |
| Organism | Pneumocystis spp. |
| Ethical Statement | The present study was approved by the Institutional Review Board/Ethics Committee of Beijing Chao-Yang Hospital (Bei-jing,China). |
| Site of Infection | None |
| Opportunistic invasive | Opportunistic |
| Sample type | Biopsy |
| Sample source | Extracted Tissue |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | MiR-150 |
| Biomarker Full Name | MiR-150 |
| Biomarker Type | Prognostic |
| Biomolecule | miRNA |
| Geographical Location | China |
| Cohort | 72 PCP patients were enrolled in the study. |
| Cohort No. | 72 |
| Age Group | 36-69 |
| P Value | None |
| Sensitivity | 0.682 |
| Specificity | 0.96 |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | Pneumocystis Pneumonia (PCP) is one of the most common opportunistic infection, which often causes life-threatening problems in HIV patients before the application of antiretro- viral drugs. Recently, non-HIV immunosuppressed patients have become the main population of Pneumocystis infection with widely used of immunosuppressive treatment. |
| Technique | PCR |
| Analysis Method | qRT-PCR |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | qRT-PCR |
| Up Regulation Down Regulation | Decrease |
| Sequence Data | None |
| External Link | None |
